Two important microbicidal pathways of phagocytes are the production of
reactive oxygen intermediates (ROI) by respiratory burst oxidase (phox)
and reactive nitrogen intermediates (RNI) by inducible nitric oxide
synthase (NOS2) (4, 7). Mice deficient in phox
(gp91phox
/
) or NOS2 (NOS2
/
)
have also demonstrated the importance of these enzymes in host defense
against a variety of pathogens (5, 18, 19). Recent data
suggest that HGE bacteria use several strategies to survive within the
hostile environment of the neutrophil. Morulae do not fuse with
lysosomes, providing one mechanism of persistence (17, 24).
HGE bacteria also inhibit the formation of ROI through selective
downregulation of the gp91phox component of the
NADPH oxidase complex (1). HGE in mice deficient in phox or
NOS2 was investigated to understand the role of ROI and RNI in
granulocytic ehrlichiosis.
This work was supported by National Institutes of Health grant
51873, the Brown-Coxe Fellowship Program, and a gift from
SmithKline Beecham Biologicals. E. Fikrig is the recipient of a
Clinical-Scientist Award in Translational Research from the Burroughs
Wellcome Fund.
We thank C. Nathan (Cornell University Medical College) and J. S. Mudgett (Merck Research Laboratories) for providing us with the
NOS2
/
mice and Debbie Beck for technical assistance.
| 1.
|
Banerjee, R.,
J. Anguita,
D. Roos, and E. Fikrig.
2000.
Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by downregulating gp91phox.
J. Immunol.
164:3946-3949[Abstract/Free Full Text].
|
| 2.
|
Bunnell, J. E.,
E. R. Trigiani,
S. R. Srinivas, and J. S. Dumler.
1999.
Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system.
J. Infect. Dis.
180:546-550[CrossRef][Medline].
|
| 3.
|
Christova, I. S., and J. S. Dumler.
1999.
Human granulocytic ehrlichiosis in Bulgaria.
Am. J. Trop. Med. Hyg.
60:58-61[Abstract].
|
| 4.
|
Clark, R. A.,
B. D. Volpp,
K. G. Leidal, and W. M. Nauseef.
1990.
Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation.
J. Clin. Investig.
85:714-721.
|
| 5.
|
Dinauer, M. C.,
M. B. Deck, and E. R. Unanue.
1997.
Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes.
J. Immunol.
158:5581-5583[Abstract].
|
| 6.
|
Dumler, J. S., and J. S. Bakken.
1998.
Human ehrlichiosis: newly recognized infections transmitted by ticks.
Annu. Rev. Med.
49:201-213[CrossRef][Medline].
|
| 7.
|
Fang, F. C.
1997.
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.
J. Clin. Investig.
99:2818-2825[Medline].
|
| 8.
|
Fehr, T.,
G. Schoedon,
B. Odermatt,
T. Holtschke,
M. Schneemann,
M. F. Bachmann,
T. W. Mak,
I. Horak, and R. M. Zinkernagel.
1997.
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.
J. Exp. Med.
185:921-931[Abstract/Free Full Text].
|
| 9.
|
Goodman, J. L.,
C. Nelson,
B. Vitale,
J. E. Madigan,
J. S. Dumler,
T. J. Kurtti, and U. G. Munderloh.
1996.
Direct cultivation of the causative agent of human granulocytic ehrlichiosis.
N. Engl. J. Med.
334:209-215[Abstract/Free Full Text].
|
| 10.
|
Heimer, R.,
A. V. Andel,
G. P. Wormser, and M. L. Wilson.
1997.
Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes.
J. Clin. Microbiol.
35:923-927[Abstract].
|
| 11.
|
Hodzic, E.,
J. W. Ijdo,
S. Feng,
P. Katavolos,
W. Sun,
C. H. Maretzki,
D. Fish,
E. Fikrig,
S. R. Telford III, and S. W. Barthold.
1998.
Granulocytic ehrlichiosis in the laboratory mouse.
J. Infect. Dis.
177:737-745[Medline].
|
| 12.
|
Holscher, C.,
G. Kohler,
U. Muller,
H. Mossmann,
G. A. Schaub, and F. Brombacher.
1998.
Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.
Infect. Immun.
66:1208-1215[Abstract/Free Full Text].
|
| 13.
|
Huang, S.,
W. Hendriks,
A. Althage,
S. Hemmi,
H. Bluethmann,
R. Kamijo,
J. Vilcek,
R. M. Zinkernagel, and M. Aguet.
1993.
Immune response in mice that lack the interferon-gamma receptor.
Science
259:1742-1745[Abstract/Free Full Text].
|
| 14.
|
Klein, M. B.,
J. S. Miller,
C. M. Nelson, and J. L. Goodman.
1997.
Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis.
J. Infect. Dis.
176:1405-1409[Medline].
|
| 15.
|
MacMicking, J. D.,
C. Nathan,
G. Hom,
N. Chartrain,
D. S. Fletcher,
M. Trumbauer,
K. Stevens,
Q. W. Xie,
K. Sokol,
N. Hutchinson, et al.
1995.
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.
Cell
81:641-650[CrossRef][Medline].
|
| 16.
|
McQuiston, J. H.,
C. D. Paddock,
R. C. Holman, and J. E. Childs.
1999.
The human ehrlichioses in the United States.
Emerg. Infect. Dis.
5:635-642[Medline].
|
| 17.
|
Mott, J.,
R. E. Barnewall, and Y. Rikihisha.
1999.
Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells.
Infect. Immun.
67:1368-1378[Abstract/Free Full Text].
|
| 18.
|
Nathan, C.
1997.
Inducible nitric oxide synthase: what difference does it make?
J. Clin. Investig.
100:2417-2423[Medline].
|
| 19.
|
Shiloh, M. U.,
J. D. MacMicking,
S. Nicholson,
J. E. Brause,
S. Potter,
M. Marino,
F. Fang,
M. Dinauer, and C. Nathan.
1999.
Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase.
Immunity
10:29-38[CrossRef][Medline].
|
| 20.
|
Sun, W.,
J. Ijdo,
S. R. Telford,
E. Hodzic,
Y. Zhang,
S. W. Barthold, and E. Fikrig.
1997.
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
J. Clin. Investig.
100:3014-3018[Medline].
|
| 21.
|
Telford, S. R., III,
J. E. Dawson,
P. Katavolos,
C. K. Warner,
C. P. Kolbert, and D. H. Persing.
1996.
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.
Proc. Natl. Acad. Sci. USA
93:6209-6214[Abstract/Free Full Text].
|
| 22.
|
van Dobbenburgh, A.,
A. P. van Dam, and E. Fikrig.
1999.
Human granulocytic ehrlichiosis in western Europe.
N. Engl. J. Med.
340:1214-1216[Free Full Text].
|
| 23.
|
Walker, D. J., and J. S. Dumler.
1997.
Human monocytic and granulocytic ehrlichiosis.
Arch. Pathol. Lab. Med.
121:785-791[Medline].
|
| 24.
|
Webster, P.,
J. Ijdo,
L. H. Chicone, and E. Fikrig.
1998.
The agent of human granulocytic ehrlichiosis resides in an endosomal compartment.
J. Clin. Investig.
102:1932-1942.
|